A study found that monoclonal antibodies amubarvimab and romlusevimab did not reduce long COVID symptoms. www.technologynetworks.com/immunology/n...
The first randomized clinical trial on monoclonal antibodies' impact on long COVID found that the combination of amubarvimab and romlusevimab did not decrease long COVID symptoms.
NIH-funded study finds long COVID affects adolescents differently than younger children highlandcountypress.com/headlines/ni...
Important š§µon our new peer-reviewed paper: The pandemic is as bad as it ever was for babies - in year to Aug 2023, 6,300 babies under 1 were admitted to hospital wholly or partly BECAUSE of Covid. They are ONLY age group where admissions have NOT gone down over time 1/17
Not medical advice. Simply sharing info. āā¦antihistamines have shown to be effective in the management of long term symptoms postāCovidā19 infection.ā pmc.ncbi.nlm.nih.gov/articles/PMC...
Treatment for Long COVID includes medications, lifestyle changes, and therapies like occupational or physical therapy. For example, if a child develops infection-associated POTS or diabetes, treatments would target those conditions.
Researchers have identified key symptoms most predictive of Long Covid in adolescents, aiding early diagnosis and treatment. #PediatricLongCovid#COVIDResearch
Thanks for sharing!
This is how you get a swarm of bots swearing children are indestructible, like if you drop them off a tall building they bounce. If you're looking for practical advice, here is the Pediatric Pacing Guide from @meactnet.bsky.social@longcovidfam.bsky.socialwww.meaction.net/resource/pac...
Find #MEAction's original Pacing Guide and Pediatric Pacing and Management Guide for ME/CFS and Long COVID, with translations.
We are an organization that supports long Covid kids. We can assure you that the symptoms are long-term and disabling for many if not most. The pediatric research to date has been very flawed. Weāre expecting better research to be published in the next 6 to 9 months.